BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 1317976)

  • 1. Carcinoma of the body and tail of the pancreas: is curative resection justified?
    Dalton RR; Sarr MG; van Heerden JA; Colby TV
    Surgery; 1992 May; 111(5):489-94. PubMed ID: 1317976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
    Shahrudin MD
    Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
    Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas.
    Ozaki H; Kinoshita T; Kosuge T; Yamamoto J; Shimada K; Inoue K; Koyama Y; Mukai K
    Cancer; 1996 Jun; 77(11):2240-5. PubMed ID: 8635090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail.
    Shimada K; Sakamoto Y; Sano T; Kosuge T
    Surgery; 2006 Mar; 139(3):288-95. PubMed ID: 16546491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
    Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
    J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of distal pancreatectomy for pancreatic adenocarcinoma.
    Goh BK; Tan YM; Cheow PC; Chung YF; Chow PK; Wong WK; Ooi LL
    Dig Surg; 2008; 25(1):32-8. PubMed ID: 18292659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resective surgical treatment of exocrine pancreas neoplasms. Retrospective study of 294 cases and review of the literature].
    Proposito D; Santoro R; Mancini B; Gallina S; Carboni M
    Ann Ital Chir; 1998; 69(1):49-62. PubMed ID: 11995039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
    Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
    Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined multiple organ resection in 16 patients with adenocarcinoma of the body or tail of the pancreas].
    Qian ZY; Miao Y; Dai CC; Xu ZK; Liu XL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):572-4. PubMed ID: 16274034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic factors influencing results of the surgical treatment of pancreatic cancer].
    Ignashov AM; Kokhanenko NIu; Lisochkin BG; Savrasov VM; Volkov ON; Dvorakovskaia IV; Lebedev EG; Kulikov IuV
    Vestn Khir Im I I Grek; 2001; 160(1):33-6. PubMed ID: 11258321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.
    Nanashima A; Yamaguchi H; Sumida Y; Abo T; Tobinaga S; Tanaka K; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2008; 55(84):873-8. PubMed ID: 18705286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery for mucin-producing pancreatic tumor.
    Yasuda H; Takada T; Amano H; Yoshida M
    Hepatogastroenterology; 1998; 45(24):2009-15. PubMed ID: 9951855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
    O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is celiac axis resection justified for T4 pancreatic body cancer?
    Yamamoto Y; Sakamoto Y; Ban D; Shimada K; Esaki M; Nara S; Kosuge T
    Surgery; 2012 Jan; 151(1):61-9. PubMed ID: 22088810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distal pancreatectomy combined with celiac axis resection in treatment of carcinoma of the body/tail of the pancreas: a single-center experience.
    Wu X; Tao R; Lei R; Han B; Cheng D; Shen B; Peng C
    Ann Surg Oncol; 2010 May; 17(5):1359-66. PubMed ID: 20198445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
    Kazanjian KK; Reber HA; Hines OJ
    Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.